The committee concluded that “It can be appropriate to authorise the use of cannabis for therapeutic uses for patients in specific clinical cases and in case of insufficient reduction or weak tolerance of therapeutics … This use could be thought of Along with or to be a substitution for specific therapies.” In January 2023, the Financial, So